Cargando…

Alveolar Macrophages Are Key Players in the Modulation of the Respiratory Antiviral Immunity Induced by Orally Administered Lacticaseibacillus rhamnosus CRL1505

The oral administration of Lacticaseibacillus rhamnosus CRL1505 differentially modulates the respiratory innate antiviral immune response triggered by Toll-like receptor 3 (TLR3) activation in infant mice, improving the resistance to Respiratory Syncytial Virus (RSV) infection. In this work, by usin...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Castillo, Valeria, Tomokiyo, Mikado, Raya Tonetti, Fernanda, Islam, Md. Aminul, Takahashi, Hideki, Kitazawa, Haruki, Villena, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550464/
https://www.ncbi.nlm.nih.gov/pubmed/33133080
http://dx.doi.org/10.3389/fimmu.2020.568636
_version_ 1783592979034800128
author Garcia-Castillo, Valeria
Tomokiyo, Mikado
Raya Tonetti, Fernanda
Islam, Md. Aminul
Takahashi, Hideki
Kitazawa, Haruki
Villena, Julio
author_facet Garcia-Castillo, Valeria
Tomokiyo, Mikado
Raya Tonetti, Fernanda
Islam, Md. Aminul
Takahashi, Hideki
Kitazawa, Haruki
Villena, Julio
author_sort Garcia-Castillo, Valeria
collection PubMed
description The oral administration of Lacticaseibacillus rhamnosus CRL1505 differentially modulates the respiratory innate antiviral immune response triggered by Toll-like receptor 3 (TLR3) activation in infant mice, improving the resistance to Respiratory Syncytial Virus (RSV) infection. In this work, by using macrophages depletion experiments and a detailed study of their production of cytokines and antiviral factors we clearly demonstrated the key role of this immune cell population in the improvement of both viral elimination and the protection against lung tissue damage induced by the CRL1505 strain. Orally administered L. rhamnosus CRL1505 activated alveolar macrophages and enhanced their ability to produce type I interferons (IFNs) and IFN-γ in response to RSV infection. Moreover, an increased expression of IFNAR1, Mx2, OAS1, OAS2, RNAseL, and IFITM3 was observed in alveolar macrophages after the oral treatment with L. rhamnosus CRL1505, which was consistent with the enhanced RSV clearance. The depletion of alveolar macrophages by the time of L. rhamnosus CRL1505 administration abolished the ability of infant mice to produce increased levels of IL-10 in response to RSV infection. However, no improvement in IL-10 production was observed when primary cultures of alveolar macrophages obtained from CRL1505-treated mice were analyzed. Of note, alveolar macrophages from the CRL1505 group had an increased production of IL-6 and IL-27 suggesting that these cells may play an important role in limiting inflammation and protecting lung function during RSV infection, by increasing the maturation and activation of Treg cells and their subsequent production of IL-10. In addition, we provided evidence of the important role of CD4(+) cells and IFN-γ in the activation of alveolar macrophages highlighting a putative pathway through which the intestinal and respiratory mucosa are communicated under the influence of L. rhamnosus CRL1505.
format Online
Article
Text
id pubmed-7550464
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-75504642020-10-29 Alveolar Macrophages Are Key Players in the Modulation of the Respiratory Antiviral Immunity Induced by Orally Administered Lacticaseibacillus rhamnosus CRL1505 Garcia-Castillo, Valeria Tomokiyo, Mikado Raya Tonetti, Fernanda Islam, Md. Aminul Takahashi, Hideki Kitazawa, Haruki Villena, Julio Front Immunol Immunology The oral administration of Lacticaseibacillus rhamnosus CRL1505 differentially modulates the respiratory innate antiviral immune response triggered by Toll-like receptor 3 (TLR3) activation in infant mice, improving the resistance to Respiratory Syncytial Virus (RSV) infection. In this work, by using macrophages depletion experiments and a detailed study of their production of cytokines and antiviral factors we clearly demonstrated the key role of this immune cell population in the improvement of both viral elimination and the protection against lung tissue damage induced by the CRL1505 strain. Orally administered L. rhamnosus CRL1505 activated alveolar macrophages and enhanced their ability to produce type I interferons (IFNs) and IFN-γ in response to RSV infection. Moreover, an increased expression of IFNAR1, Mx2, OAS1, OAS2, RNAseL, and IFITM3 was observed in alveolar macrophages after the oral treatment with L. rhamnosus CRL1505, which was consistent with the enhanced RSV clearance. The depletion of alveolar macrophages by the time of L. rhamnosus CRL1505 administration abolished the ability of infant mice to produce increased levels of IL-10 in response to RSV infection. However, no improvement in IL-10 production was observed when primary cultures of alveolar macrophages obtained from CRL1505-treated mice were analyzed. Of note, alveolar macrophages from the CRL1505 group had an increased production of IL-6 and IL-27 suggesting that these cells may play an important role in limiting inflammation and protecting lung function during RSV infection, by increasing the maturation and activation of Treg cells and their subsequent production of IL-10. In addition, we provided evidence of the important role of CD4(+) cells and IFN-γ in the activation of alveolar macrophages highlighting a putative pathway through which the intestinal and respiratory mucosa are communicated under the influence of L. rhamnosus CRL1505. Frontiers Media S.A. 2020-09-29 /pmc/articles/PMC7550464/ /pubmed/33133080 http://dx.doi.org/10.3389/fimmu.2020.568636 Text en Copyright © 2020 Garcia-Castillo, Tomokiyo, Raya Tonetti, Islam, Takahashi, Kitazawa and Villena. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Garcia-Castillo, Valeria
Tomokiyo, Mikado
Raya Tonetti, Fernanda
Islam, Md. Aminul
Takahashi, Hideki
Kitazawa, Haruki
Villena, Julio
Alveolar Macrophages Are Key Players in the Modulation of the Respiratory Antiviral Immunity Induced by Orally Administered Lacticaseibacillus rhamnosus CRL1505
title Alveolar Macrophages Are Key Players in the Modulation of the Respiratory Antiviral Immunity Induced by Orally Administered Lacticaseibacillus rhamnosus CRL1505
title_full Alveolar Macrophages Are Key Players in the Modulation of the Respiratory Antiviral Immunity Induced by Orally Administered Lacticaseibacillus rhamnosus CRL1505
title_fullStr Alveolar Macrophages Are Key Players in the Modulation of the Respiratory Antiviral Immunity Induced by Orally Administered Lacticaseibacillus rhamnosus CRL1505
title_full_unstemmed Alveolar Macrophages Are Key Players in the Modulation of the Respiratory Antiviral Immunity Induced by Orally Administered Lacticaseibacillus rhamnosus CRL1505
title_short Alveolar Macrophages Are Key Players in the Modulation of the Respiratory Antiviral Immunity Induced by Orally Administered Lacticaseibacillus rhamnosus CRL1505
title_sort alveolar macrophages are key players in the modulation of the respiratory antiviral immunity induced by orally administered lacticaseibacillus rhamnosus crl1505
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550464/
https://www.ncbi.nlm.nih.gov/pubmed/33133080
http://dx.doi.org/10.3389/fimmu.2020.568636
work_keys_str_mv AT garciacastillovaleria alveolarmacrophagesarekeyplayersinthemodulationoftherespiratoryantiviralimmunityinducedbyorallyadministeredlacticaseibacillusrhamnosuscrl1505
AT tomokiyomikado alveolarmacrophagesarekeyplayersinthemodulationoftherespiratoryantiviralimmunityinducedbyorallyadministeredlacticaseibacillusrhamnosuscrl1505
AT rayatonettifernanda alveolarmacrophagesarekeyplayersinthemodulationoftherespiratoryantiviralimmunityinducedbyorallyadministeredlacticaseibacillusrhamnosuscrl1505
AT islammdaminul alveolarmacrophagesarekeyplayersinthemodulationoftherespiratoryantiviralimmunityinducedbyorallyadministeredlacticaseibacillusrhamnosuscrl1505
AT takahashihideki alveolarmacrophagesarekeyplayersinthemodulationoftherespiratoryantiviralimmunityinducedbyorallyadministeredlacticaseibacillusrhamnosuscrl1505
AT kitazawaharuki alveolarmacrophagesarekeyplayersinthemodulationoftherespiratoryantiviralimmunityinducedbyorallyadministeredlacticaseibacillusrhamnosuscrl1505
AT villenajulio alveolarmacrophagesarekeyplayersinthemodulationoftherespiratoryantiviralimmunityinducedbyorallyadministeredlacticaseibacillusrhamnosuscrl1505